The myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type

Vascular and Endovascular Surgery

Volumn 42, Issue 2, 2008, Pages 101-112

  Pipinos, Iraklis I ^a,c   Judge, Andrew R ^b   Selsby, Joshua T ^b   Zhu, Zhen ^a   Swanson, Stanley A ^a   Nella, Aikaterini A ^a   Dodd, Stephen L ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c 983280 Nebraska Medical Center ^*  (United States)

Author keywords

Bioenergetics; Mitochondrial dysfunction; Oxidative stress; Peripheral arterial occlusive disease; Skeletal muscle

Indexed keywords

BIOENERGY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; MUSCLE CELL; MUSCLE ISCHEMIA; MYOPATHY; NEUROPATHY; OXIDATIVE STRESS; PATHOGENESIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REPERFUSION; REVIEW;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; AUTONOMIC NERVOUS SYSTEM; ENERGY METABOLISM; EXERCISE; HUMANS; MITOCHONDRIA, MUSCLE; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DISEASES; OXIDATIVE STRESS; PERIPHERAL VASCULAR DISEASES; REPERFUSION INJURY;

EID: 42449109144     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/1538574408315995     Document Type: Review

References (77)

1. Pipinos II, Judge AR, Selsby JT, et al. The myopathy of peripheral arterial occlusive disease: Part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction. Vasc Endovascular Surg. 2008 ; 41: 481-489.
2. Wallace DC Mitochondrial defects in cardiomyopathy and neuromuscular disease. Am Heart J. 2000 ; 139: 70S - 85S.
3. McLennan HR, Degli Esposti M. The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species. J Bioenerg Biomembr. 2000 ; 32: 153-162.
4. St-Pierre J., Buckingham JA, Roebuck SJ, Brand MD Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem. 2002 ; 277: 44784-44790.
5. Kwong LK, Sohal RS Substrate and site specificity of hydrogen peroxide generation in mouse mitochondria. Arch Biochem Biophys. 1998 ; 350: 118-126.
6. Lenaz G., D'Aurelio M., Merlo Pich M., et al. Mitochondrial bioenergetics in aging. Biochim Biophys Acta. 2000 ; 1459: 397-404.
7. Moghaddas S., Hoppel CL, Lesnefsky EJ Aging defect at the QO site of complex III augments oxyradical production in rat heart interfibrillar mitochondria. Arch Biochem Biophys. 2003 ; 414: 59-66.
8. Pipinos II, Judge AR, Zhu Z., et al. Mitochondrial defects and oxidative damage in skeletal muscle of patients with peripheral arterial disease. Free Rad Biol Med. 2006 ; 41: 262-269.
9. Alexeyev MF, Ledoux SP, Wilson GL Mitochondrial DNA and aging. Clin Sci (Lond). 2004 ; 107: 355-364.
10. Balaban RS, Nemoto S., Finkel T. Mitochondria, oxidants, and aging. Cell. 2005 ; 120: 483-495.
11. Dufour E., Larsson NG Understanding aging: revealing order out of chaos. Biochim Biophys Acta. 2004 ; 1658: 122-132.
12. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956 ; 11: 298-300.
13. Harper ME, Bevilacqua L., Hagopian K., et al. Ageing, oxidative stress, and mitochondrial uncoupling. Acta Physiol Scand. 2004 ; 182: 321-331.
14. Makris KI, Nella AA, Zhu Z., et al. Mitochondriopathy of peripheral arterial disease. Vascular. 2007 ; 15: 336-343.
15. Tzagoloff A., Myers AM Genetics of mitochondrial biogenesis. Annu Rev Biochem. 1986 ; 55: 249-285.
16. Wallace DC Diseases of the mitochondrial DNA. Annu Rev Biochem. 1992 ; 61: 1175-1212.
17. Miquel J. An integrated theory of aging as the result of mitochondrial-DNA mutation in differentiated cells. Arch Gerontol Geriatr. 1991 ; 12: 99-117.
18. Bhat HK, Hiatt WR, Hoppel CL, Brass EP Skeletal muscle mitochondrial DNA injury in patients with unilateral peripheral arterial disease. Circulation. 1999 ; 99: 807-812.
19. Cooper JM, Mann VM, Schapira AH Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: effect of ageing. J Neurol Sci. 1992 ; 113: 91-98.
20. Shigenaga MK, Hagen TM, Ames BN Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci U S A. 1994 ; 91: 10771-10778.
21. Tisi PV, Shearman CP Biochemical and inflammatory changes in the exercising claudicant. Vasc Med. 1998 ; 3: 189-198.
22. Tisi PV, Shearman CP The evidence for exercise-induced inflammation in intermittent claudication: should we encourage patients to stop walking ? Eur J Vasc Endovasc Surg. 1998 ; 15: 7-17.
23. Mueller T., Dieplinger B., Gegenhuber A., et al. Serum total 8-iso-prostaglandin F2alpha: a new and independent predictor of peripheral arterial disease. J Vasc Surg. 2004 ; 40: 768-773.
24. Langlois M., Duprez D., Delanghe J., et al. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation. 2001 ; 103: 1863-1868.
25. Jialal I., Grundy SM Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. J Clin Invest. 1991 ; 87: 597-601.
26. Edwards AT, Blann AD, Suarez-Mendez VJ, et al. Systemic responses in patients with intermittent claudication after treadmill exercise. Br J Surg. 1994 ; 81: 1738-1741.
27. Pessah-Rasmussen H., Stavenow L., Seidegard J. Low glutathione transferase activity in intermittent claudication. Acta Chir Scand Suppl. 1988 ; 548: A59.
28. Weiss SJ Oxygen, ischemia and inflammation. Acta Physiol Scand Suppl. 1986 ; 548: 9-37.
29. Spark JI, Robinson JM, Gallavin L., et al. Patients with chronic critical limb ischaemia have reduced total antioxidant capacity and impaired nutritional status. Eur J Vasc Endovasc Surg. 2002 ; 24: 535-539.
30. Krijgsman B., Papadakis JA, Ganotakis ES, et al. The effect of peripheral vascular disease on the serum levels of natural anti-oxidants: bilirubin and albumin. Int Angiol. 2002 ; 21: 44-52.
31. Larsson H., Haeger K. Plasma and muscle tocopherol contents during vitamin E therapy in arterial disease. Pharmacol Clin. 1968 ; 1: 72.
32. Judge AR, Dodd SL Oxidative damage to skeletal muscle following an acute bout of contractile claudication. Atherosclerosis. 2003 ; 171: 219-224.
33. Sirsjo A., Kagedal B., Arstrand K., et al. Altered glutathione levels in ischemic and postischemic skeletal muscle: difference between severe and moderate ischemic insult. J Trauma. 1996 ; 41: 123-128.
34. Ishikawa T., Sies H. Cardiac transport of glutathione disulfide and S-conjugate. Studies with isolated perfused rat heart during hydroperoxide metabolism. J Biol Chem. 1984 ; 259: 3838-3843.
35. Jandric-Balen M., Bozikov V., Bistrovic D., et al. Antioxidant enzymes activity in patients with peripheral vascular disease, with and without presence of diabetes mellitus. Coll Antropol. 2003 ; 27: 735-743.
36. Hickman P., Harrison DK, Hill A., et al. Exercise in patients with intermittent claudication results in the generation of oxygen derived free radicals and endothelial damage. Adv Exp Med Biol. 1994 ; 361: 565-570.
37. Turton EP, Coughlin PA, Kester RC, Scott DJ Exercise training reduces the acute inflammatory response associated with claudication. Eur J Vasc Endovasc Surg. 2002 ; 23: 309-316.
38. Silvestro A., Scopacasa F., Oliva G., et al. Vitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication. Atherosclerosis. 2002 ; 165: 277-283.
39. Khaira HS, Maxwell SR, Shearman CP Antioxidant consumption during exercise in intermittent claudication. Br J Surg. 1995 ; 82: 1660-1662.
40. Wijnen MH, Coolen SA, Vader HL, et al. Antioxidants reduce oxidative stress in claudicants. J Surg Res. 2001 ; 96: 183-187.
41. Boyd AM, Marks J. Treatment of intermittent claudication. A reappraisal of the value of alpha-tocopherol. Angiology. 1963 ; 14: 198-208.
42. Haeger K. The treatment of peripheral occlusive arterial disease with alpha-tocopherol as compared with vasodilator agents and antiprothrombin (dicumarol). Vasc Dis. 1968 ; 5: 199-213.
43. Livingstone PD, Jones C. Treatment of intermittent claudication with vitamin E. Lancet. 1958 ; 2: 602-604.
44. Williams HT, Fenna D., Macbeth RA Alpha tocopherol in the treatment of intermittent claudication. Surg Gynecol Obstet. 1971 ; 132: 662-666.
45. Arosio E., De Marchi S., Zannoni M., et al. Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial. Mayo Clin Proc. 2002 ; 77: 754-759.
46. Hickman P., McCollum PT, Belch JJ Neutrophils may contribute to the morbidity and mortality of claudicants. Br J Surg. 1994 ; 81: 790-798.
47. Pipinos II, Shepard AD, Anagnostopoulos PV, et al. Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle. J Vasc Surg. 2000 ; 31: 944-952.
48. Pipinos II, Sharov VG, Shepard AD, et al. Abnormal mitochondrial respiration in skeletal muscle in patients with peripheral arterial disease. J Vasc Surg. 2003 ; 38: 827-832.
49. Ugalde V., Wineinger MA, Kappagoda CT, et al. Sensory axonopathy in mild to moderate peripheral arterial disease. Am J Phys Med Rehabil. 1998 ; 77: 59-64 ;quiz 65-66.
50. England JD, Ferguson MA, Hiatt WR, Regensteiner JG Progression of neuropathy in peripheral arterial disease. Muscle Nerve. 1995 ; 18: 380-387.
51. Laghi Pasini F., Pastorelli M., Beermann U., et al. Peripheral neuropathy associated with ischemic vascular disease of the lower limbs. Angiology. 1996 ; 47: 569-577.
52. Nukada H., van Rij AM, Packer SG, McMorran PD Pathology of acute and chronic ischaemic neuropathy in atherosclerotic peripheral vascular disease. Brain. 1996 ; 119: 1449-1460.
53. Weber F., Ziegler A. Axonal neuropathy in chronic peripheral arterial occlusive disease. Muscle Nerve. 2002 ; 26: 471-476.
54. Papapetropoulou V., Tsolakis J., Terzis S., et al. Neurophysiologic studies in peripheral arterial disease. J Clin Neurophysiol. 1998 ; 15: 447-450.
55. Koopman JP, de Vries AC, de Weerd AW Neuromuscular disorders in patients with intermittent claudication. Eur J Surg. 1996 ; 162: 443-446.
56. England JD, Regensteiner JG, Ringel SP, et al. Muscle denervation in peripheral arterial disease. Neurology. 1992 ; 42: 994-999.
57. Eames RA, Lange LS Clinical and pathological study of ischaemic neuropathy. J Neurol Neurosurg Psychiatry. 1967 ; 30: 215-226.
58. Farinon AM, Marbini A., Gemignani F., et al. Skeletal muscle and peripheral nerve changes caused by chronic arterial insufficiency: significance and clinical correlations-histological, histochemical and ultrastructural study. Clin Neuropathol. 1984 ; 3: 240-252.
59. Makitie J., Teravainen H. Histochemical changes in striated muscle in patients with intermittent claudication. Arch Pathol Lab Med. 1977 ; 101: 658-663.
60. Regensteiner JG, Wolfel EE, Brass EP, et al. Chronic changes in skeletal muscle histology and function in peripheral arterial disease. Circulation. 1993 ; 87: 413-421.
61. Clyne CA, Weller RO, Bradley WG, et al. Ultrastructural and capillary adaptation of gastrocnemius muscle to occlusive peripheral vascular disease. Surgery. 1982 ; 92: 434-440.
62. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the american association for vascular surgery/society for vascular surgery, society for cardiovascular angiography and interventions, society for vascular medicine and biology, society of interventional radiology, and the acc/aha task force on practice guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease): endorsed by the american association of cardiovascular and pulmonary rehabilitation; national heart, lung, and blood institute; society for vascular nursing; transatlantic inter-society consensus; and vascular disease foundation. Circulation. 2006 ; 113: 463e - 654e.
63. Boyko EJ, Ahroni JH, Davignon D., et al. Diagnostic utility of the history and physical examination for peripheral vascular disease among patients with diabetes mellitus. J Clin Epidemiol. 1997 ; 50: 659-668.
64. Khan NA, Rahim SA, Anand SS, et al. Does the clinical examination predict lower extremity peripheral arterial disease ? JAMA. 2006 ; 295: 536-546.
65. Scott W., Stevens J., Binder-Macleod SA Human skeletal muscle fiber type classifications. Phys Ther. 2001 ; 81: 1810-1816.
66. Staron RS, Kraemer WJ, Hikida RS, et al. Fiber type composition of four hindlimb muscles of adult Fisher 344 rats. Histochem Cell Biol. 1999 ; 111: 117-123.
67. Houmard JA, Weidner ML, Gavigan KE, et al. Fiber type and citrate synthase activity in the human gastrocnemius and vastus lateralis with aging. J Appl Physiol. 1998 ; 85: 1337-1341.
68. Gosker HR, van Mameren H., van Dijk PJ, et al. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J. 2002 ; 19: 617-625.
69. D'Antona G., Pellegrino MA, Adami R., et al. The effect of ageing and immobilization on structure and function of human skeletal muscle fibres. J Physiol. 2003 ; 552: 499-511.
70. Ohira Y., Yoshinaga T., Nonaka I., et al. Histochemical responses of human soleus muscle fibers to long-term bedrest with or without countermeasures. Jpn J Physiol. 2000 ; 50: 41-47.
71. Steinacker JM, Opitz-Gress A., Baur S., et al. Expression of myosin heavy chain isoforms in skeletal muscle of patients with peripheral arterial occlusive disease. J Vasc Surg. 2000 ; 31: 443-449.
72. McGuigan MR, Bronks R., Newton RU, et al. Muscle fiber characteristics in patients with peripheral arterial disease. Med Sci Sports Exerc. 2001 ; 33: 2016-2021.
73. Bylund AC, Hammarsten J., Holm J., Schersten T. Enzyme activities in skeletal muscles from patients with peripheral arterial insufficiency. Eur J Clin Invest. 1976 ; 6: 425-429.
74. Hiatt WR, Regensteiner JG, Wolfel EE, et al. Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease. J Appl Physiol. 1996 ; 81: 780-788.
75. Jansson E., Johansson J., Sylven C., Kaijser L. Calf muscle adaptation in intermittent claudication. Side-differences in muscle metabolic characteristics in patients with unilateral arterial disease. Clin Physiol. 1988 ; 8: 17-29.
76. Lundgren F., Bennegard K., Elander A., et al. Substrate exchange in human limb muscle during exercise at reduced blood flow. Am J Physiol. 1988 ; 255: 1156H - 1164H.
77. Wang H., Hiatt WR, Barstow TJ, Brass EP Relationships between muscle mitochondrial DNA content, mitochondrial enzyme activity and oxidative capacity in man: alterations with disease. Eur J Appl Physiol Occup Physiol. 1999 ; 80: 22-27.